foxo4-dri apoptosis alleviates age-related testosterone secretion insufficiency by targeting senescent Leydig cells in aged mice FOXO4-DRI: The Senolytic Peptide That

24mg total 300 mcg per spray 99%+ purity (HPLC) Third-party tested Janoshik Identity confirmed Certificate of Analysis Tested by Janoshik 11/10/2025 Key Ingredients Tripeptide-copper complex studied for its ability to modulate over 4,000 human genes

Anesthesiology 105:599612

Originally developed by researchers at Washington State University, it was designed to explore the cognitive role of the AT4 receptor

The set contains three peptides: BPC-157 (10 mg), TB-500 (10 mg) and GHK-Cu (50 mg), supplied lyophilised

Peptides like GHK-Cu are unlike topical solutions which only address surface concerns

Highly recommend!Posted onRoger BlackAugust 25, 2025Trustindex verifies that the original source of the review is Google.Very attentive and receptive of my needs